Anaptysbio Inc share price logo

Anaptysbio Inc Share Price

NASDAQ: ANAB

Small Cap

$20.17

-3.23

(-13.80%)

as on

Anaptysbio Inc Stock Performance

as on September 16, 2025 at 1:29 am IST

  • Day's Low

    Day's High

    $20.24
    $24.07
    downward going graph

    -0.35%

    Downside

    19.34%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $12.21
    $40.55
    downward going graph

    39.46%

    Downside

    101.04%

    Upside

    downward going graph

Anaptysbio Inc share price movements today

Previous Close
$23.40
Open
$23.76
Volume
1.1M
Day's Low - High
$20.24 - $24.07
52 Week Low - High
$12.21 - $40.55

Anaptysbio Inc Historical Returns

1 Month Return
+ 16.19 %
3 Month Return
+ 0.34 %
1 Year Return
-41.98 %
3 Year Return
-8.59 %
5 Year Return
+ 50.58 %

Anaptysbio Inc Stock Fundamentals & Key Indicators

Check Anaptysbio Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$654.6M

EPS (TTM)

-4.7991

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-5.91

Industry PE ratio

-3.8535542168674697

P/B Ratio

0

PEG Ratio

0

EBITDA

-85.6M

Revenue (TTM)

123.2M

Profit Margin

-107.66%

Return On Equity TTM

2887600.00%

Anaptysbio Inc Stock Valuation

Track how Anaptysbio Inc P/E has moved over time to understand its valuation trends.

Anaptysbio Inc in the last 5 years

  • Overview

  • Trends

Lowest (90.65x)

September 30, 2021

Today (-5.91x)

September 15, 2025

Industry (-3.85x)

September 15, 2025

Highest (90.65x)

September 30, 2021

LowHigh

Today’s Price to Earnings Ratio: -5.91x

Anaptysbio Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Anaptysbio Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Anaptysbio Inc image
Anaptysbio Inc
BUY$654.6M50.58%-5.91-107.66%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$61.1B256.98%-505.15-12.96%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$38.7BNANA-3.89%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$101.1B47.85%28.0731.86%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Anaptysbio Inc Stock including INR - Dollar returns

The Anaptysbio Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Anaptysbio Inc investment value today

Current value as on today

₹54,998

Returns

₹45,002

(-45%)

Returns from Anaptysbio Inc Stock

₹49,988 (-49.99%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Anaptysbio Inc Stock

Based on 16 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 16 analysts, 75% of analysts recommend a 'BUY' rating for Anaptysbio Inc. Average target price of $45.5

Anaptysbio Inc Share Price Target

Get share price movements and forecasts by analysts on Anaptysbio Inc.

What analysts predicted

55.67%UPSIDE

Target Price

$45.5

Current Price

$20.17

Analyzed by

16 Analysts

Target

$45.50

Anaptysbio Inc target price $45.5, a slight upside of 55.67% compared to current price of $20.17. According to 16 analysts rating.

Anaptysbio Inc Stock's Interest Amongst Investors

Search interest for Anaptysbio Inc Stock has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-70% versus previous 30 day period

Anaptysbio Inc Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
1
3
3
9
7
10
30
43
27
22
Gross Profit
0
2
2
8
6
10
29
43
27
21
Operating Income
-44
-40
-37
-42
-42
-40
-22
-9
-27
-26
EBITDA
-39
-34
-32
-36
-37
-35
-16
-3
-27
-18
Interest Expense
4
4
4
4
6
10
15
17
18
19
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-44
-39
-37
-42
-43
-46
-32
-21
-39
-38
Income Tax Expense
4
4
4
4
0
0
0
0
0
0
Net Income
-48
-39
-37
-42
-43
-46
-32
-21
-39
-38
Net Profit Margin
-3525.84%
-1151.59%
-1124.41%
-468.75%
-612.01%
-425.30%
-109.44%
-50.53%
-141.62%
-173.52%

Anaptysbio Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
17
16
10
5
8
75
63
10
17
91
Gross Profit
0
1
-19
-51
-91
-5
-35
7
14
91
Operating Income
-3
-3
-28
-66
-107
-23
-56
-115
-164
-114
EBITDA
-4
-3
-28
-59
-95
-19
-55
-105
-143
-92
Interest Expense
0
0
1
1
1
3
1
21
18
50
Depreciation
-
-
0
0
0
0
2
2
2
2
Income Before Tax
-5
-4
-30
-61
-97
-19
-57
-128
-163
-145
Income Tax Expense
0
0
1
0
0
0
0
0
0
0
Net Income
-5
-4
-30
-61
-97
-19
-57
-128
-163
-145
Net Profit Margin
-30.76%
-25.53%
-300.70%
-1233.12%
-1216.70%
-26.56%
-90.53%
-1251.33%
-953.66%
-159.10%

Anaptysbio Inc Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
-39
-37
-42
-43
-46
-32
-21
-39
-38
Operating Cash Flow
-25
-36
-34
-44
-14
-10
-66
-10
-40
Investing Cash Flow
-20
30
49
68
-2
58
-29
14
36
Financing Cash Flow
-13
-3
-5
-6
34
71
27
-28
-50
Change in Cash
-59
-8
9
17
18
119
-68
-24
-54

Anaptysbio Inc Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-4
-30
-61
-97
-19
-57
-128
-163
-145
Operating Cash Flow
-9
-19
-48
-69
-14
-45
-73
-120
-135
Investing Cash Flow
0
-243
-142
131
94
38
-394
144
95
Financing Cash Flow
8
292
223
-4
0
252
44
-59
127
Change in Cash
0
29
32
57
79
245
-424
-35
87

Global Institutional Holdings in Anaptysbio Inc

Funds
Holdings
EcoR1 Capital, LLC
28.17%
First Light Asset Management, LLC
16.56%
Point72 Asset Management, L.P.
8.47%
BlackRock Inc
7.78%
FMR Inc
6.81%
See all

Insights on Anaptysbio Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, ANAB stock has moved up by 5.5%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -39.32M → -38.63M (in $), with an average increase of 1.8% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 132.1%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 117.6%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 43.11M → 22.26M (in $), with an average decrease of 27.7% per quarter

About Anaptysbio Inc

founded in 2005, anaptysbio, inc. is a privately-held company focused on the generation of antibody therapeutics, and the leader in the use of somatic hypermutation (shm) for antibody discovery and optimization. anaptysbio is building a pipeline of novel therapeutic antibody product candidates, including differentiated programs in cancer immunotherapy, inflammation, muscle wasting disorders, fibrosis and antibody-drug conjugate applications. anaptysbio’s proprietary shm-xel platform, which couples fully human antibody libraries with in vitro somatic hypermutation (shm) in mammalian cells to generate high affinity lead candidates, replicates key features of the human immune system and overcomes limitations of prior antibody technologies. by harnessing the natural mechanism of antibody maturation under controlled conditions, shm-xel allows for the selection of optimal antibody properties such as high affinity, function, cross-reactivity, epitope diversity and manufacturability. the c
OrganisationAnaptysbio Inc
Headquarters10770 Wateridge Circle, San Diego, CA, United States, 92121-5801
IndustryHealth Technology
CEOMr. Daniel R. Faga
E-voting on sharesClick here to vote

Key Management of Anaptysbio Inc

Name

Title

Dr. Martin Dahl Ph.D.

Senior Vice President of Research

Mr. Benjamin Stone

Chief Business Officer

Mr. Douglas A. Rich M.B.A.

Senior Vice President of CMC

Mr. Dennis M. Mulroy

Chief Financial Officer

Dr. Paul F. Lizzul FAAD, M.B.A., M.D., M.P.H., Ph.D.

Chief Medical Officer

Ms. Beth Mueller

Senior Vice President of Human Resources

Ms. Monique Da Silva

Senior Vice President of Corporate Affairs

Ms. Priya Raina

Senior Vice President of Clinical Operations

Mr. Daniel R. Faga

President, CEO & Director

Mr. Eric J. Loumeau

Chief Legal Officer

FAQs

What is Anaptysbio Inc share price today?

Anaptysbio Inc share price today is $20.17 as on at the close of the market. Anaptysbio Inc share today touched a day high of $24.07 and a low of $20.24.

What is the 52 week high and 52 week low for Anaptysbio Inc share?

Anaptysbio Inc share touched a 52 week high of $40.55 on and a 52 week low of $12.21 on . Anaptysbio Inc stock price today i.e. is closed at $20.17,which is 50.26% down from its 52 week high and 65.19% up from its 52 week low.

What is Anaptysbio Inc's market capitalisation today?

Anaptysbio Inc market capitalisation is $0.00T as on .

How to invest in Anaptysbio Inc Stock (ANAB) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Anaptysbio Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Anaptysbio Inc Shares that will get you 0.0744 shares as per Anaptysbio Inc share price of $20.17 per share as on September 16, 2025 at 1:29 am IST.

What is the minimum amount required to buy Anaptysbio Inc Stock (ANAB) from India?

Indian investors can start investing in Anaptysbio Inc (ANAB) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Anaptysbio Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Anaptysbio Inc share’s latest price of $20.17 as on September 16, 2025 at 1:29 am IST, you will get 0.4958 shares of Anaptysbio Inc. Learn more about fractional shares .

What are the returns that Anaptysbio Inc has given to Indian investors in the last 5 years?

Anaptysbio Inc stock has given 50.58% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?